# KYPROLIS
> **NDA202714** · New Drug Application · Sponsor: ONYX PHARMS AMGEN · Approved 2012-07-20
## Drug
- **FDA Application Number:** NDA202714
- **Application type:** New Drug Application
- **Brand name:** KYPROLIS
- **Generic name:** CARFILZOMIB
- **Active ingredients:** CARFILZOMIB
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ONYX PHARMS AMGEN
- **Manufacturer:** Onyx Pharmaceuticals, Inc.
- **First approval:** 2012-07-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202714)
---
*AI Analytics · CC0 1.0*